Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 466
Filter
1.
Sci Total Environ ; 877: 162733, 2023 Jun 15.
Article in English | MEDLINE | ID: mdl-36924956

ABSTRACT

This study focuses on the relevance of small watersheds in the macroplastic pollution of coastal environments. It aims to identify and quantify in terms of composition, number and mass, current riverine flows of floating macroplastics (>2.5 cm). Estimates are based on 66 visual monitoring of total litter over a 4-year-period (2016-2019) in a small coastal Mediterranean river, the Têt River (NW Mediterranean Sea). The plastic fraction represented 97 % of the observed litter, mainly cigarette butts (20.5 %), polystyrene fragments (18.8 %) and light packaging (16.3 %). The Tet River is characterized by frequent flash-flood events caused by heavy rain, that can induce a sudden rise of the water discharge. Such hydroclimatic forcing greatly influence macroplastic flows, both in terms of their average compositions and loads. We have estimated that 354,000 macroplastic items, corresponding to 0.65 tons, are discharged annually from the Tet River into the sea, and that 73 % of them are released during rain events (∼6 % of the year). The short observation distance from the water surface allowed to exhibit the great abundance of small litter (80 % of them were < 10 cm) and to evaluate to 1.8 g the average mass of floating plastics. Our results suggest that remediation actions must be taken on rainy days and target small litter in order to significantly limit macroplastic inputs from rivers to the sea. Moreover, the large share of cigarette butts in macrolitter inputs demonstrates that reducing ocean pollution cannot be achieved solely by improving waste management, but that changes in social behavior are also needed to stem waste production at the source.

2.
J Pediatr Urol ; 14(3): 268.e1-268.e5, 2018 06.
Article in English | MEDLINE | ID: mdl-29534861

ABSTRACT

INTRODUCTION: Endoscopic injection of a bulking agent is a common first-line approach to the treatment of vesicoureteral reflux (VUR). While early outcomes are comparable to open ureteroneocystotomy, 5-25% of children will eventually develop recurrent reflux necessitating repeat injections or open ureteral reimplantation. OBJECTIVE: To determine whether prior endoscopic injection of a bulking agent impacts outcomes of subsequent open ureteral reimplantation. STUDY DESIGN: Using a retrospective cohort design, radiographic and clinical outcomes of open ureteral reimplantation were compared between patients with and without prior endoscopic correction of reflux. Surgical and hospitalization data were also compared between groups and a cost comparison was performed to assess differences in healthcare costs between the two cohorts. Units of analysis included total ureters or total patients. For certain variables, subanalysis of unilateral versus bilateral reimplantation was included. RESULTS: A total of 258 patients underwent open reimplantation for VUR between 2007 and 2016 by five pediatric urologists. Final analysis (see Summary Table) included 192 patients with pre-operative and postoperative voiding cystourethrogram (VCUG) and follow-up data at a median 4.95 months. Among 317 reimplanted refluxing ureters, radiographic resolution was reached in 26/27 (96.3%) patients with and 279/290 (96.2%) without prior endoscopic treatment (P = 0.981). Clinical success was achieved in 17/17 (100%) patients with and 174/175 (99.4%) without prior endoscopic treatment (P = 0.755). There were no statistically significant differences between duration of surgery or length of hospital stay. There were no statistically significant differences between total charges, total costs, and operating room (OR) costs between groups. DISCUSSION: This study indicated that prior endoscopic injection of a bulking agent did not impact the outcomes or costs of subsequent open ureteroneocystotomy. While prior studies have demonstrated tissue changes associated with injection of a bulking agent, these did not seem to significantly impact the difficulty of later open surgery or the success rates compared to patients who proceeded directly to open correction of reflux. CONCLUSION: Open ureteral reimplantation for recurrent VUR after failed endoscopic injection of a bulking agent was safe and effective, with comparable outcomes and costs to open surgery in patients without prior endoscopic correction.


Subject(s)
Hospital Costs , Replantation/methods , Ureter/surgery , Urologic Surgical Procedures/methods , Vesico-Ureteral Reflux/surgery , Adolescent , Child , Child, Preschool , Costs and Cost Analysis , Cystography , Cystoscopy , Female , Follow-Up Studies , Humans , Infant , Male , Replantation/economics , Retrospective Studies , Urologic Surgical Procedures/economics , Vesico-Ureteral Reflux/diagnosis , Vesico-Ureteral Reflux/economics , Young Adult
3.
J Synchrotron Radiat ; 23(Pt 6): 1474-1483, 2016 11 01.
Article in English | MEDLINE | ID: mdl-27787253

ABSTRACT

Multi-modal characterization of polycrystalline materials by combined use of three-dimensional (3D) X-ray diffraction and imaging techniques may be considered as the 3D equivalent of surface studies in the electron microscope combining diffraction and other imaging modalities. Since acquisition times at synchrotron sources are nowadays compatible with four-dimensional (time lapse) studies, suitable mechanical testing devices are needed which enable switching between these different imaging modalities over the course of a mechanical test. Here a specifically designed tensile device, fulfilling severe space constraints and permitting to switch between X-ray (holo)tomography, diffraction contrast tomography and topotomography, is presented. As a proof of concept the 3D characterization of an Al-Li alloy multicrystal by means of diffraction contrast tomography is presented, followed by repeated topotomography characterization of one selected grain at increasing levels of deformation. Signatures of slip bands and sudden lattice rotations inside the grain have been shown by means of in situ topography carried out during the load ramps, and diffraction spot peak broadening has been monitored throughout the experiment.

4.
Z Gastroenterol ; 54(11): 1223-1229, 2016 Nov.
Article in German | MEDLINE | ID: mdl-27723912

ABSTRACT

Biosimilar medicinal products (biosimilars) have been available in Europe for 10 years, allowing a wide use particularly in oncology. Biosimilars are being developed and approved by means of scientifically sound principles to assure close similarity with the reference products with regard to quality, efficacy, and safety. The scientific principles for establishing biosimilarity are the same as those for demonstrating comparability after a change in the manufacturing process of an already licensed biological. Nevertheless, many clinicians voiced concerns about biosimilars related to their pharmaceutical quality, efficacy (particularly in extrapolated indications), safety (especially immunogenicity), and interchangeability with the originator product. The availability of biosimilars would strengthen the economic competition on the pharmaceutical market, provide opportunities to improve healthcare access, and contribute to the financial sustainability of European healthcare systems. Biosimilars can be considered therapeutic alternatives to the reference product. To date, no data has been published revealing any disadvantages of the biosimilars' use. This article aims to acquaint clinicians, particularly oncologists and haematologists, with the biosimilar concept as they are going to be confronted with a constantly increasing number of biosimilars due to patent expirations in the near future. Furthermore, it provides information on scientific principles guiding biosimilar development and regulatory requirements. This should minimise unfounded fears and concerns among clinicians. Additionally, we provide information on the interchangeability between originator products and biosimilars to assist clinicians in making evidence-based, appropriate, and cost-effective treatment choices for their patients.


Subject(s)
Antineoplastic Agents/administration & dosage , Biosimilar Pharmaceuticals/administration & dosage , Drug Approval/methods , Drug Substitution/trends , Gastrointestinal Neoplasms/drug therapy , Antineoplastic Agents/adverse effects , Biosimilar Pharmaceuticals/adverse effects , European Union , Evidence-Based Medicine , Gastrointestinal Neoplasms/diagnosis , Humans , Therapeutic Equivalency , Treatment Outcome
5.
Leukemia ; 30(6): 1230-6, 2016 06.
Article in English | MEDLINE | ID: mdl-26859081

ABSTRACT

We randomized 3375 adults with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome to test whether increasingly intensive chemotherapies assigned at study-entry and analyzed on an intent-to-treat basis improved outcomes. In total, 1529 subjects <60 years were randomized to receive: (1) a first course of induction therapy with high-dose cytarabine and mitoxantrone (HAM) or with standard-dose cytarabine, daunorubicin and 6-thioguanine (TAD) followed by a second course of HAM; (2) granulocyte-colony stimulating factor (G-CSF) or no G-CSF before induction and consolidation courses; and (3) high-dose therapy and an autotransplant or maintenance chemotherapy. In total, 1846 subjects ⩾60 years were randomized to receive: (1) a first induction course of HAM or TAD and second induction course of HAM (if they had bone marrow blasts ⩾5% after the first course); and (2) G-CSF or no G-CSF as above. Median follow-up was 7.4 years (range, 1 day to 14.7 years). Five-year event-free survivals (EFSs) for subjects receiving a first induction course of HAM vs TAD were 17% (95% confidence interval, 15, 18%) vs 16% (95% confidence interval 14, 18%; P=0.719). Five-year EFSs for subjects randomized to receive or not receive G-CSF were 19% (95% confidence interval 16, 21%) vs 16% (95% confidence interval 14, 19%; P=0.266). Five-year relapse-free survivals (RFSs) for subjects <60 years receiving an autotransplant vs maintenance therapy were 43% (95% confidence interval 40, 47%) vs 40 (95% confidence interval 35, 44%; P=0.535). Many subjects never achieved pre-specified landmarks and consequently did not receive their assigned therapies. These data indicate the limited impact of more intensive therapies on outcomes of adults with AML. Moreover, none of the more intensive therapies we tested improved 5-year EFS, RFS or any other outcomes.


Subject(s)
Leukemia, Myeloid, Acute/drug therapy , Adult , Aminoglutethimide/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cytarabine/therapeutic use , Danazol/therapeutic use , Disease-Free Survival , Granulocyte Colony-Stimulating Factor , Humans , Induction Chemotherapy , Leukemia, Myeloid, Acute/mortality , Leukemia, Myeloid, Acute/therapy , Middle Aged , Mitoxantrone/therapeutic use , Stem Cell Transplantation , Survival Rate , Tamoxifen/therapeutic use , Transplantation, Autologous , Treatment Outcome , Young Adult
7.
Nat Commun ; 6: 6098, 2015 Jan 14.
Article in English | MEDLINE | ID: mdl-25586429

ABSTRACT

Many physical and mechanical properties of crystalline materials depend strongly on their internal structure, which is typically organized into grains and domains on several length scales. Here we present dark-field X-ray microscopy; a non-destructive microscopy technique for the three-dimensional mapping of orientations and stresses on lengths scales from 100 nm to 1 mm within embedded sampling volumes. The technique, which allows 'zooming' in and out in both direct and angular space, is demonstrated by an annealing study of plastically deformed aluminium. Facilitating the direct study of the interactions between crystalline elements is a key step towards the formulation and validation of multiscale models that account for the entire heterogeneity of a material. Furthermore, dark-field X-ray microscopy is well suited to applied topics, where the structural evolution of internal nanoscale elements (for example, positioned at interfaces) is crucial to the performance and lifetime of macro-scale devices and components thereof.

8.
Anaesthesist ; 63(11): 883-94; quiz 895-6, 2014 Nov.
Article in German | MEDLINE | ID: mdl-25318621

ABSTRACT

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint and systemic manifestations. As the prevalence in the adult population is approximately 1 %, anesthesia management in patients with RA has to be performed on a regular basis. Besides elective orthopedic surgery, e.g. surgery of the cervical spine, all other types of planned and emergency surgery should also be anticipated. Administering anesthesia to a patient with RA can be challenging not only due to a higher incidence of difficult intubation but also because of various organ manifestations as well as an elevated cardiovascular risk. Furthermore, possible complications should be considered in patients with chronic medication, particularly in patients treated with immunomodulating drugs. Therefore, a careful preoperative evaluation, preparation for possible difficult airway management and a selective anesthesia management in patients with RA can prevent possible complications.


Subject(s)
Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/therapy , Perioperative Care/methods , Airway Management , Anesthesia/methods , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/surgery , Humans , Orthopedic Procedures
9.
Analyst ; 139(22): 5765-71, 2014 Nov 21.
Article in English | MEDLINE | ID: mdl-25274183

ABSTRACT

Traditional neutron imaging is based on the attenuation of a neutron beam through scattering and absorption upon traversing a sample of interest. It offers insight into the sample's material distribution at high spatial resolution in a non-destructive way. In this work, it is expanded to include the diffracted neutrons that were ignored so far and obtain a crystallographic distribution (grain mapping). Samples are rotated in a cold neutron beam of limited wavelength band. Projections of the crystallites formed by the neutrons they diffract are captured on a two dimensional imaging detector. Their positions on the detector reveal their orientation whereas the projections themselves are used to reconstruct the shape of the grains. Indebted to established synchrotron diffraction contrast tomography, this 'cold neutron diffraction contrast tomography' is performed on recrystallized aluminium for experimental comparison between both. Differences between set-up and method are discussed, followed by the application range in terms of sample properties (crystallite size and number, mosaicity and typical materials). Neutron diffraction contrast tomography allows to study large grains in bulky metallic structures.

10.
Environ Geochem Health ; 36(5): 995-1014, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24737418

ABSTRACT

In order to calculate budgets of particulate matter and sediment-bound contaminants leaving the continental shelf of the Gulf of Lion (GoL), settling particles were collected in March 2011 during a major storm, using sediment traps. The collecting devices were deployed in the Cap de Creus submarine canyon, which represents the main export route. Particulate matter samples were analyzed to obtain mass fluxes and contents in organic carbon, Al, Cr, Co, Ni, Cu, Zn, Cd, Pb and La, Nd and Sm. The natural or anthropogenic origin of trace metals was assessed using enrichment factors (EFs). Results are that Zn, Cu and Pb appeared to be of anthropogenic origin, whereas Ni, Co and Cr appeared to be strictly natural. The anthropogenic contribution of all elements (except Cd) was refined by acid-leaching (HCl 1 N) techniques, confirming that Zn, Cu and Pb are the elements that are the most enriched. However, although those elements are highly labile (59-77%), they do not reflect severe enrichment (EFs <4). Most particles originate from the Rhone River. This has been confirmed by two different tracing procedures using rare earth elements ratios and concentrations of acid-leaching residual trace metals. Our results hence indicate that even in this western extremity of the GoL, storm events mainly export Rhone-derived particles via the Cap de Creus submarine canyons to the deep-sea environments. This export of material is significant as it represents about a third of the annual PTM input from the Rhone River.


Subject(s)
Environmental Monitoring , Metals/analysis , Particulate Matter/analysis , Water Pollutants, Chemical/analysis , Weather , Mediterranean Sea , Rivers , Water Pollution/statistics & numerical data
11.
Klin Padiatr ; 225 Suppl 1: S62-72, 2013 May.
Article in English | MEDLINE | ID: mdl-23700060

ABSTRACT

Between 1981 and 2000, 6 609 children (<18 years of age) were treated in 5 consecutive trials of the Berlin-Frankfurt-Münster (BFM) study group for childhood acute lymphoblastic leukemia (ALL). Patients were treated in up to 82 centers in Germany, Austria, and Switzerland. Probability of 10-year event-free survival (survival) improved from 65% (77%) in study ALL-BFM 81-78% (85%) in ALL-BFM 95. In parallel to relapse reduction, major efforts focused on reducing acute and late toxicity through advanced risk adaptation of treatment. The major findings derived from these ALL-BFM trials were as follows: 1) preventive cranial radiotherapy could be safely reduced to 12 Gy in T-ALL and high-risk ALL patients and eliminated in non-high-risk non-T-ALL patients, if it was replaced by high-dose and intrathecal methotrexate; 2) omission of delayed reintensification severely impaired outcome of low-risk patients; 3) 6 months less maintenance therapy caused an increase in systemic relapses; 4) slow response to an initial 7-day prednisone window was identified as adverse prognostic factor; 5) condensed induction therapy resulted in a significant improvement of outcome; 6) the daunorubicin dose in induction could be safely reduced in low-risk patients; 7) intensification of consolidation/reintensification treatment led to considerable improvement of outcome in high-risk patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/history , Medical Oncology/history , Pediatrics/history , Precursor Cell Lymphoblastic Leukemia-Lymphoma/history , Randomized Controlled Trials as Topic/history , Asparaginase/history , Child , Cyclophosphamide/history , Cytarabine/history , Daunorubicin/history , Europe , Germany , History, 20th Century , History, 21st Century , Humans , Mercaptopurine/history , Methotrexate/history , Prednisone/history , Vincristine/history
12.
Klin Padiatr ; 225 Suppl 1: S34-9, 2013 May.
Article in English | MEDLINE | ID: mdl-23700065

ABSTRACT

BACKGROUND: Flow cytometry immunophenotyping (FCM) is an undispensable tool for the diagnosis and for the treatment stratification of childhood acute lymphoblastic leukemia. The correlation of the EGIL-classification with prognostically relevant parameters like age, prednisone response and risk group is analyzed. PATIENTS: Between March 2000 and June 2009 12 patients less than 1 year of age, 1 836 patients with 1 to less than 6 years, 620 patients with 6 to less than 10 years, 615 patients with 10 to less than 15 years and 275 patients with 15 to less than 19 years were analyzed with a comprehensive 4-color antibody panel and classified according to the EGIL recommendations. METHODS: Bone marrow or peripheral blood mononuclear cells were isolated by ficoll gradient centrifugation, washed and stained with fluorochrome-conjugated antigen-specific monoclonal antibodies. Cell preparations were acquired and analyzed on a flow cytometer. RESULTS: Centralized FCM was performed for 2 775 patients (82.6%) with B-cell precursor acute lymphoblastic leukemia, 493 patients (14.7%) with T-cell acute lymphoblastic leukemia and 90 patients (2,7%) with biphenotypic acute leukemia. There was a slight overall predominance of male (56.1%) over female (43.9%) patients. Patients with B-cell precursor ALL had a slightly more favourable outcome with a 10 y pEFS of 78 ± 1.0%, compared to patients with a T-ALL or BAL (biphenotypic acute leukemia) phenotype with a 10 y pEFS of 74 ± 1.8% (n.s.) or 69 ± 9.0% (p<0.009), respectively. CONCLUSIONS: FCM according to the EGIL recommendations not only provides diagnostic lineage determination and subclassification but also enables an initial prognostic orientation before MRD (minimal residual disease)-based risk stratification becomes available.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cell Lineage/genetics , Leukemia, Biphenotypic, Acute/drug therapy , Leukemia, Biphenotypic, Acute/genetics , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics , Adolescent , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Asparaginase/adverse effects , Asparaginase/therapeutic use , Child , Child, Preschool , Cyclophosphamide/adverse effects , Cyclophosphamide/therapeutic use , Cytarabine/adverse effects , Cytarabine/therapeutic use , Daunorubicin/adverse effects , Daunorubicin/therapeutic use , Female , Flow Cytometry , Humans , Immunophenotyping , Infant , Leukemia, Biphenotypic, Acute/classification , Leukemia, Biphenotypic, Acute/mortality , Male , Mercaptopurine/adverse effects , Mercaptopurine/therapeutic use , Methotrexate/adverse effects , Methotrexate/therapeutic use , Neoplasm, Residual/classification , Neoplasm, Residual/drug therapy , Neoplasm, Residual/genetics , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/classification , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/mortality , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/classification , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/mortality , Prednisone/adverse effects , Prednisone/therapeutic use , Prognosis , Survival Analysis , Vincristine/adverse effects , Vincristine/therapeutic use
14.
J Appl Microbiol ; 114(4): 1082-91, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23289707

ABSTRACT

AIMS: The aim of this study was to analyse the bacterial microbiota of water kefir using culture-independent methods. METHODS AND RESULTS: We compared four water kefirs of different origins using 16S rDNA amplicon sequencing and ARDRA. The microbiota consisted of different proportions of the genera Lactobacillus (Lact.), Leuconostoc (Leuc.), Acetobacter (Acet.) and Gluconobacter. Surprisingly, varying but consistently high numbers of sequences representing members of the genus Bifidobacterium (Bif.) were found in all kefirs. Whereas part of the bifidobacterial sequences could be assigned to Bifidobacterium psychraerophilum, a majority of sequences identical to each other could not be assigned to any known species. A nearly full-length sequence of the latter exhibited a beyond-species similarity (96.4%) with the sequence from the closest relative species Bif. psychraerophilum. A Bifidobacterium-specific ARDRA analysis reflected the abundance of the novel Bifidobacterium species by revealing its unique MboI restriction profile. Attempts to isolate the bifidobacteria were successful for Bif. psychraerophilum only. CONCLUSIONS: The complexity of the water kefir microbiota has been underestimated in previously studies. The occurrence of bifidobacteria as part of the consortium is novel. SIGNIFICANCE AND IMPACT OF THE STUDY: These data give new insights into the understanding of the complexity of food fermentations and underline the need for approaches detecting noncultivable organisms.


Subject(s)
Bifidobacterium/genetics , Cultured Milk Products/microbiology , Microbial Consortia , Acetobacter/genetics , Bifidobacterium/classification , Bifidobacterium/isolation & purification , DNA, Bacterial/genetics , Food Microbiology , Gluconobacter/genetics , High-Throughput Nucleotide Sequencing , Lactobacillus/genetics , Leuconostoc/genetics , Phylogeny , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Water
15.
J Surg Res ; 178(1): 268-79, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22482753

ABSTRACT

INTRODUCTION: The aim of the present study was to analyze the impact of cryosurgery (CRYO) on liver metastases compared to other thermoablative techniques. In a rat liver metastases model, evidence for tumor cell spread was analyzed comparing CRYO, radiofrequency ablation (RFA), and laser-induced thermotherapy (LITT). METHODS: In an experimental study, we compared cell spillage in the washout of isolated perfused rat livers undergoing thermal ablation. Within the same model, CC531-GFP rat liver tumors were treated with CRYO, RFA, or LITT and the number of vital tumor cells within the perfusate was measured. Matrix metalloproteinases (MMP-2, MMP-9) were analyzed after in vivo ablation of rat colorectal liver metastases in the third experimental model. RESULTS: Our data showed pronounced washout of cells after CRYO with a higher amount of intravascular cells and cell detritus compared to RFA and LITT. Only the effluent fluid of cryosurgery-treated livers revealed GFP-stained tumor cells. MMP-2 and MMP-9 expression was significantly higher after cryosurgery than after RFA and LITT. CONCLUSION: When using thermoablative techniques, intravascular metastatic cell spillage is highest in CRYO, and increased expression of matrix metalloproteinases may further facilitate tumor cell spread. Therefore, RFA and LITT may be preferable whenever surgical resection of liver tumors is impossible.


Subject(s)
Colorectal Neoplasms/pathology , Hepatectomy/adverse effects , Hepatectomy/methods , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Neoplastic Cells, Circulating/pathology , Animals , Body Fluids/cytology , Body Fluids/metabolism , Catheter Ablation/adverse effects , Catheter Ablation/methods , Cell Line, Tumor , Colorectal Neoplasms/metabolism , Cryosurgery/adverse effects , Cryosurgery/methods , Female , Green Fluorescent Proteins/genetics , Hyperthermia, Induced/adverse effects , Hyperthermia, Induced/methods , Liver Neoplasms/metabolism , Male , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Neoplasm Transplantation , Rats , Rats, Sprague-Dawley
16.
Z Rheumatol ; 71(2): 108-10, 112-8, 2012 Feb.
Article in German | MEDLINE | ID: mdl-22370801

ABSTRACT

The off-label use of approved pharmaceuticals outside the authorized status is implemented in pharmacotherapy of many diseases, especially for rare diseases and in cases of therapy resistance. The German regulations are presented and analyzed and the relative literature is discussed.


Subject(s)
Insurance, Pharmaceutical Services/economics , Insurance, Pharmaceutical Services/legislation & jurisprudence , National Health Programs/economics , National Health Programs/legislation & jurisprudence , Off-Label Use/economics , Off-Label Use/legislation & jurisprudence , Rare Diseases/drug therapy , Reimbursement Mechanisms/economics , Reimbursement Mechanisms/legislation & jurisprudence , Adult , Angiogenesis Inhibitors/adverse effects , Angiogenesis Inhibitors/economics , Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal, Humanized/adverse effects , Antibodies, Monoclonal, Humanized/economics , Antibodies, Monoclonal, Humanized/therapeutic use , Bevacizumab , Child , Cost-Benefit Analysis/economics , Cost-Benefit Analysis/legislation & jurisprudence , Drug Approval/economics , Drug Approval/legislation & jurisprudence , Drug Resistance , Evidence-Based Medicine/economics , Evidence-Based Medicine/legislation & jurisprudence , Germany , Guideline Adherence/economics , Guideline Adherence/legislation & jurisprudence , Humans , Orphan Drug Production/economics , Orphan Drug Production/legislation & jurisprudence , Physician's Role , Ranibizumab , Rare Diseases/economics , Treatment Outcome
17.
Methods Inf Med ; 51(3): 199-209, 2012.
Article in English | MEDLINE | ID: mdl-21915435

ABSTRACT

BACKGROUND: Health care network eHealth.Braunschweig has been started in the South-East region of Lower Saxony in Germany in 2009. It composes major health care players, participants from research institutions and important local industry partners. OBJECTIVES: The objective of this paper is firstly to describe the relevant regional characteristics and distinctions of the eHealth.Braunschweig health care network and to inform about the goals and structure of eHealth.Braunschweig; secondly to picture and discuss the main concepts and domain fields which are addressed in the health care network; and finally to discuss the architectural challenges of eHealth.Braunschweig regarding the addressed domain fields and defined requirements. METHODS: Based on respective literature and former conducted projects we discuss the project structure and goals of eHealth.Braunschweig, depict major domain fields and requirements gained in workshops with participants and discuss the architectural challenges as well as the architectural approach of eHealth.Braunschweig network. RESULTS: The regional healthcare network eHealth.Braunschweig has been established in April 2009. Since then the network has grown constantly and a sufficient progress in network activities has been achieved. The main domain fields have been specified in different workshops with network participants and an architectural realization approach for the transinstitutional information system architecture in the healthcare network has been developed. However, the effects on quality of information processing and quality of patient care have not been proved yet. Systematic evaluation studies have to be done in future in order to investigate the impact of information and communication technology on the quality of information processing and the quality of patient care. CONCLUSIONS: In general, the aspects described in this paper are expected to contribute to a systematic approach for the establishment of regional health care networks with lasting and sustainable effects on patient-centered health care in a regional context.


Subject(s)
Delivery of Health Care, Integrated/organization & administration , Medical Informatics/organization & administration , Patient-Centered Care/organization & administration , Telemedicine/organization & administration , Computer Systems , Cooperative Behavior , Geography , Germany , Humans , Methicillin-Resistant Staphylococcus aureus , Program Evaluation , Registries
18.
Leukemia ; 26(5): 1012-9, 2012 May.
Article in English | MEDLINE | ID: mdl-22064352

ABSTRACT

The t(10;11)(p12;q14) is a recurring chromosomal translocation that gives rise to the CALM/AF10 fusion gene, which is found in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma. We analyzed the fusion transcripts in 20 new cases of CALM/AF10-positive leukemias, and compared the gene expression profile of 10 of these to 125 patients with other types of leukemia and 10 normal bone marrow samples. Based on gene set enrichment analyses, the CALM/AF10-positive samples showed significant upregulation of genes involved in chromatin assembly and maintenance and DNA repair process, and downregulation of angiogenesis and cell communication genes. Interestingly, we observed a striking upregulation of four genes located immediately centromeric to the break point of the t(10;11)(p12;q14) on 10p12 (COMMD3 (COMM domain containing 3), BMI1 (B lymphoma Mo-MLV insertion region 1 homolog), DNAJC1 (DnaJ (Hsp40) homolog subfamily C member 1) and SPAG6 (sperm associated antigen 6)). We also conducted semiquantitative reverse transcriptase-PCR analysis on leukemic blasts from a murine CALM/AF10 transplantation model that does not have the translocation. Commd3, Bmi1 and Dnajc1, but not Spag6 were upregulated in these samples. These results strongly indicate that the differential regulation of these three genes is not due to the break point effect but as a consequence of the CALM/AF10 fusion gene expression, though the mechanism of regulation is not well understood.


Subject(s)
Chromatin Assembly and Disassembly/genetics , Chromosome Fragile Sites , Chromosomes, Human, Pair 10 , DNA Repair/genetics , Leukemia/genetics , Monomeric Clathrin Assembly Proteins/genetics , Transcription Factors/genetics , Up-Regulation , Animals , Humans , Mice , Reverse Transcriptase Polymerase Chain Reaction , Translocation, Genetic
19.
Leukemia ; 24(12): 2005-13, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20944675

ABSTRACT

Precursor T-cell acute lymphoblastic leukemia (T-ALL) remains an important challenge in pediatric oncology. Because of the particularly poor prognosis of relapses, it is vital to identify molecular risk factors allowing early and effective treatment stratification. Activating NOTCH1 mutations signify a favorable prognosis in patients treated on ALL-BFM protocols. We have now tested if NOTCH pathway activation at different steps has similar clinical effects and if multiple mutations in this pathway function synergistically. Analysis of a validation set of 151 T-ALL patients and of the total cohort of 301 patients confirms the low relapse rate generally and the overall favorable effect of activating NOTCH1 mutations. Subgroup analysis shows that the NOTCH1 effect in ALL-BFM is restricted to patients with rapid early treatment response. Inactivation of the ubiquitin ligase FBXW7 is associated with rapid early treatment response and synergizes with NOTCH1 receptor activation. However, the effect of FBXW7 inactivation is separable from NOTCH1 activation by not synergizing with NOTCH1 mutations in predicting favorable long-term outcome, which can probably be explained by the interaction of FBXW7 with other clients. Finally, the comparison with other European protocols suggests that the NOTCH effect is treatment dependent generally and may depend on the intensity of central nervous system-directed therapy specifically.


Subject(s)
Cell Cycle Proteins/genetics , F-Box Proteins/genetics , Mutation , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics , Prednisone/therapeutic use , Receptor, Notch1/genetics , Ubiquitin-Protein Ligases/genetics , Cell Cycle Proteins/physiology , Child , F-Box Proteins/physiology , F-Box-WD Repeat-Containing Protein 7 , Humans , Treatment Outcome , Ubiquitin-Protein Ligases/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...